ReP USP - Resultado da busca

Artigo de periodico
Epithelial–mesenchymal transition signaling and prostate cancer stem cells: emerging biomarkers and opportunities for precision therapeutics (2021)
Souza, Luiz Paulo Chaves de; Melo, Camila Morais ; Saggioro, Fabiano Pinto ; Reis, Rodolfo Borges dos ; Squire, Jeremy Andrew
Source: Genes. Unidades: SVOI, FMRP
Subjects: NEOPLASIAS PROSTÁTICAS, IMUNOTERAPIA, ONCOGENES, GENES SUPRESSORES DE TUMOR, MUTAÇÃO GENÉTICA, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Luiz Paulo Chaves de et al. Epithelial–mesenchymal transition signaling and prostate cancer stem cells: emerging biomarkers and opportunities for precision therapeutics. Genes, v. 12, n. 12, p. 1-18, 2021Tradução . . Disponível em: https://doi.org/10.3390/genes12121900. Acesso em: 17 nov. 2024.
APA
Souza, L. P. C. de, Melo, C. M., Saggioro, F. P., Reis, R. B. dos, & Squire, J. A. (2021). Epithelial–mesenchymal transition signaling and prostate cancer stem cells: emerging biomarkers and opportunities for precision therapeutics. Genes, 12( 12), 1-18. doi:10.3390/genes12121900
NLM
Souza LPC de, Melo CM, Saggioro FP, Reis RB dos, Squire JA. Epithelial–mesenchymal transition signaling and prostate cancer stem cells: emerging biomarkers and opportunities for precision therapeutics [Internet]. Genes. 2021 ; 12( 12): 1-18.[citado 2024 nov. 17 ] Available from: https://doi.org/10.3390/genes12121900
Vancouver
Souza LPC de, Melo CM, Saggioro FP, Reis RB dos, Squire JA. Epithelial–mesenchymal transition signaling and prostate cancer stem cells: emerging biomarkers and opportunities for precision therapeutics [Internet]. Genes. 2021 ; 12( 12): 1-18.[citado 2024 nov. 17 ] Available from: https://doi.org/10.3390/genes12121900
Artigo de periodico
Value of adding the apparent diffusion coefficient to capsular contact for the prediction of extracapsular extension in prostate cancer (2020)
Silva Filho, Antonio Cordeiro da ; Rocha, Tamara Oliveira ; Elias Júnior, Jorge ; Barros, Marcus Vinicius de Castro ; Ribeiro-Silva, Alfredo ; Reis, Rodolfo Borges dos ; Muglia, Valdair Francisco
Source: Radiologia Brasileira. Unidades: FMRP, SVOI
Subjects: NEOPLASIAS PROSTÁTICAS, RESSONÂNCIA MAGNÉTICA, ESTADIAMENTO DE NEOPLASIAS, PRÓSTATA, ADENOCARCINOMA, IMAGEM POR RESSONÂNCIA MAGNÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA FILHO, Antonio Cordeiro da et al. Value of adding the apparent diffusion coefficient to capsular contact for the prediction of extracapsular extension in prostate cancer. Radiologia Brasileira, v. 53, n. 6, p. 381-389, 2020Tradução . . Disponível em: https://doi.org/10.1590/0100-3984.2019.0123. Acesso em: 17 nov. 2024.
APA
Silva Filho, A. C. da, Rocha, T. O., Elias Júnior, J., Barros, M. V. de C., Ribeiro-Silva, A., Reis, R. B. dos, & Muglia, V. F. (2020). Value of adding the apparent diffusion coefficient to capsular contact for the prediction of extracapsular extension in prostate cancer. Radiologia Brasileira, 53( 6), 381-389. doi:10.1590/0100-3984.2019.0123
NLM
Silva Filho AC da, Rocha TO, Elias Júnior J, Barros MV de C, Ribeiro-Silva A, Reis RB dos, Muglia VF. Value of adding the apparent diffusion coefficient to capsular contact for the prediction of extracapsular extension in prostate cancer [Internet]. Radiologia Brasileira. 2020 ; 53( 6): 381-389.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1590/0100-3984.2019.0123
Vancouver
Silva Filho AC da, Rocha TO, Elias Júnior J, Barros MV de C, Ribeiro-Silva A, Reis RB dos, Muglia VF. Value of adding the apparent diffusion coefficient to capsular contact for the prediction of extracapsular extension in prostate cancer [Internet]. Radiologia Brasileira. 2020 ; 53( 6): 381-389.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1590/0100-3984.2019.0123
Artigo de periodico
PTEN loss in Gleason grade 7 prostate tumors exhibits intratumoral heterogeneity and is associated with unfavorable pathological features (2019)
Albuquerque, Clarissa Gondim Picanço de; Vidotto, Thiago ; Pereira, C. S.; Saggioro, Fabiano Pinto ; Jamaspishvili, T.; Koti, M.; Berman, D. M.; Squire, Jeremy Andrew ; Reis, Rodolfo Borges dos
Source: Applied Cancer Research. Unidades: SVOI, FMRP
Subjects: NEOPLASIAS DOS GENITAIS MASCULINOS, ESCORE DO TESTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALBUQUERQUE, Clarissa Gondim Picanço de et al. PTEN loss in Gleason grade 7 prostate tumors exhibits intratumoral heterogeneity and is associated with unfavorable pathological features. Applied Cancer Research, v. 39, 2019Tradução . . Disponível em: https://doi.org/10.1186/s41241-018-0071-y. Acesso em: 17 nov. 2024.
APA
Albuquerque, C. G. P. de, Vidotto, T., Pereira, C. S., Saggioro, F. P., Jamaspishvili, T., Koti, M., et al. (2019). PTEN loss in Gleason grade 7 prostate tumors exhibits intratumoral heterogeneity and is associated with unfavorable pathological features. Applied Cancer Research, 39. doi:10.1186/s41241-018-0071-y
NLM
Albuquerque CGP de, Vidotto T, Pereira CS, Saggioro FP, Jamaspishvili T, Koti M, Berman DM, Squire JA, Reis RB dos. PTEN loss in Gleason grade 7 prostate tumors exhibits intratumoral heterogeneity and is associated with unfavorable pathological features [Internet]. Applied Cancer Research. 2019 ; 39[citado 2024 nov. 17 ] Available from: https://doi.org/10.1186/s41241-018-0071-y
Vancouver
Albuquerque CGP de, Vidotto T, Pereira CS, Saggioro FP, Jamaspishvili T, Koti M, Berman DM, Squire JA, Reis RB dos. PTEN loss in Gleason grade 7 prostate tumors exhibits intratumoral heterogeneity and is associated with unfavorable pathological features [Internet]. Applied Cancer Research. 2019 ; 39[citado 2024 nov. 17 ] Available from: https://doi.org/10.1186/s41241-018-0071-y
Artigo de periodico
PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells (2019)
Vidotto, Thiago ; Saggioro, Fabiano Pinto ; Jamaspishvili, Tamara; Chesca, Deise Lúcia; Albuquerque, Clarissa Gondim Picanço de; Reis, Rodolfo Borges dos ; Graham, Charles H.; Berman, David M.; Siemens, D. Robert; Squire, Jeremy Andrew ; Koti, Madhuri
Source: The Prostate. Unidades: SVOI, FMRP
Subjects: PRÓSTATA, NEOPLASIAS, SISTEMA IMUNE, REGULAÇÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIDOTTO, Thiago et al. PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells. The Prostate, v. 79, n. 9, p. 969-979, 2019Tradução . . Disponível em: https://doi.org/10.1002/pros.23808. Acesso em: 17 nov. 2024.
APA
Vidotto, T., Saggioro, F. P., Jamaspishvili, T., Chesca, D. L., Albuquerque, C. G. P. de, Reis, R. B. dos, et al. (2019). PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells. The Prostate, 79( 9), 969-979. doi:10.1002/pros.23808
NLM
Vidotto T, Saggioro FP, Jamaspishvili T, Chesca DL, Albuquerque CGP de, Reis RB dos, Graham CH, Berman DM, Siemens DR, Squire JA, Koti M. PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells [Internet]. The Prostate. 2019 ; 79( 9): 969-979.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1002/pros.23808
Vancouver
Vidotto T, Saggioro FP, Jamaspishvili T, Chesca DL, Albuquerque CGP de, Reis RB dos, Graham CH, Berman DM, Siemens DR, Squire JA, Koti M. PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells [Internet]. The Prostate. 2019 ; 79( 9): 969-979.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1002/pros.23808
Artigo de periodico
Direct immunofluorescence as a helpful tool for the differential diagnosis of oral lichen planus and oral lichenoid lesions (2018)
Yamanaka, Yasmin; Yamashita, Mauricio Eiji de Almeida Santos; Innocentini, Lara Maria ALencar Ramos; Macedo, Leandro D.; Chahud, Fernando; Ribeiro-Silva, Alfredo; Roselino, Ana Maria Ferreira; Rocha, Maria José Alves da; Motta, Ana Carolina Fragoso
Source: The American Journal of Dermatopathology. Unidades: FORP, FMRP, SVOI
Subjects: IMUNOFLUORESCÊNCIA, LÍQUEN PLANO BUCAL, PATOLOGIA BUCAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YAMANAKA, Yasmin et al. Direct immunofluorescence as a helpful tool for the differential diagnosis of oral lichen planus and oral lichenoid lesions. The American Journal of Dermatopathology, v. 40, n. 7, p. 491-497, 2018Tradução . . Disponível em: https://doi.org/10.1097/dad.0000000000001071. Acesso em: 17 nov. 2024.
APA
Yamanaka, Y., Yamashita, M. E. de A. S., Innocentini, L. M. A. L. R., Macedo, L. D., Chahud, F., Ribeiro-Silva, A., et al. (2018). Direct immunofluorescence as a helpful tool for the differential diagnosis of oral lichen planus and oral lichenoid lesions. The American Journal of Dermatopathology, 40( 7), 491-497. doi:10.1097/dad.0000000000001071
NLM
Yamanaka Y, Yamashita ME de AS, Innocentini LMALR, Macedo LD, Chahud F, Ribeiro-Silva A, Roselino AMF, Rocha MJA da, Motta ACF. Direct immunofluorescence as a helpful tool for the differential diagnosis of oral lichen planus and oral lichenoid lesions [Internet]. The American Journal of Dermatopathology. 2018 ; 40( 7): 491-497.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1097/dad.0000000000001071
Vancouver
Yamanaka Y, Yamashita ME de AS, Innocentini LMALR, Macedo LD, Chahud F, Ribeiro-Silva A, Roselino AMF, Rocha MJA da, Motta ACF. Direct immunofluorescence as a helpful tool for the differential diagnosis of oral lichen planus and oral lichenoid lesions [Internet]. The American Journal of Dermatopathology. 2018 ; 40( 7): 491-497.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1097/dad.0000000000001071
Artigo de periodico
Impact of the canonical Wnt pathway activation on the pathogenesis and prognosis of adamantinomatous craniopharyngiomas (2018)
Jucá, Carlos Eduardo Barros; Colli, Leandro Machado; Martins, Clarissa Silva; Campanini, Marina Lanciotti; Paixão, Beatriz; Jucá, Renata Viana; Saggioro, Fabiano Pinto; Oliveira, Ricardo Santos de; Moreira, Ayrton Custódio; Machado, Hélio Rubens; Neder, Luciano; Antonini, Sonir Roberto Rauber; Castro, Margaret de
Source: Hormone and Metabolic Research. Unidades: FMRP, SVOI
Subjects: NEOPLASIAS CEREBRAIS, GLÂNDULA PITUITÁRIA, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JUCÁ, Carlos Eduardo Barros et al. Impact of the canonical Wnt pathway activation on the pathogenesis and prognosis of adamantinomatous craniopharyngiomas. Hormone and Metabolic Research, v. 50, n. 7, p. 575-581, 2018Tradução . . Disponível em: https://doi.org/10.1055/a-0593-5956. Acesso em: 17 nov. 2024.
APA
Jucá, C. E. B., Colli, L. M., Martins, C. S., Campanini, M. L., Paixão, B., Jucá, R. V., et al. (2018). Impact of the canonical Wnt pathway activation on the pathogenesis and prognosis of adamantinomatous craniopharyngiomas. Hormone and Metabolic Research, 50( 7), 575-581. doi:10.1055/a-0593-5956
NLM
Jucá CEB, Colli LM, Martins CS, Campanini ML, Paixão B, Jucá RV, Saggioro FP, Oliveira RS de, Moreira AC, Machado HR, Neder L, Antonini SRR, Castro M de. Impact of the canonical Wnt pathway activation on the pathogenesis and prognosis of adamantinomatous craniopharyngiomas [Internet]. Hormone and Metabolic Research. 2018 ; 50( 7): 575-581.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1055/a-0593-5956
Vancouver
Jucá CEB, Colli LM, Martins CS, Campanini ML, Paixão B, Jucá RV, Saggioro FP, Oliveira RS de, Moreira AC, Machado HR, Neder L, Antonini SRR, Castro M de. Impact of the canonical Wnt pathway activation on the pathogenesis and prognosis of adamantinomatous craniopharyngiomas [Internet]. Hormone and Metabolic Research. 2018 ; 50( 7): 575-581.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1055/a-0593-5956
Artigo de periodico
Th17 response of borderline-lepromatous leprosy inhibits rash manifestation of Dapsone Hypersensitivity Syndrome: case report (2018)
Vanzela, Tamara de Nardo; Bernardes Filho, Fred; Wambier, Carlos Gustavo; Faria, Francesca Maia; Foss, Norma Tiraboschi; Frade, Marco Andrey Cipriani
Source: The American Journal of Dermatopathology. Unidades: SVOI, FMRP
Subjects: HIPERSENSIBILIDADE A DROGAS, HANSENÍASE, LINFÓCITOS T, INTERLEUCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VANZELA, Tamara de Nardo et al. Th17 response of borderline-lepromatous leprosy inhibits rash manifestation of Dapsone Hypersensitivity Syndrome: case report. The American Journal of Dermatopathology, v. 40, n. 3, p. 205-208, 2018Tradução . . Disponível em: https://doi.org/10.1097/dad.0000000000000839. Acesso em: 17 nov. 2024.
APA
Vanzela, T. de N., Bernardes Filho, F., Wambier, C. G., Faria, F. M., Foss, N. T., & Frade, M. A. C. (2018). Th17 response of borderline-lepromatous leprosy inhibits rash manifestation of Dapsone Hypersensitivity Syndrome: case report. The American Journal of Dermatopathology, 40( 3), 205-208. doi:10.1097/dad.0000000000000839
NLM
Vanzela T de N, Bernardes Filho F, Wambier CG, Faria FM, Foss NT, Frade MAC. Th17 response of borderline-lepromatous leprosy inhibits rash manifestation of Dapsone Hypersensitivity Syndrome: case report [Internet]. The American Journal of Dermatopathology. 2018 ; 40( 3): 205-208.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1097/dad.0000000000000839
Vancouver
Vanzela T de N, Bernardes Filho F, Wambier CG, Faria FM, Foss NT, Frade MAC. Th17 response of borderline-lepromatous leprosy inhibits rash manifestation of Dapsone Hypersensitivity Syndrome: case report [Internet]. The American Journal of Dermatopathology. 2018 ; 40( 3): 205-208.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1097/dad.0000000000000839
Artigo de periodico
Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection (2018)
Petrilli, Raquel; Eloy, Josimar de Oliveira ; Saggioro, Fabiano Pinto ; Chesca, Deise Lúcia; Souza, Marina Claro de; Dias, Marcos Vinicios Salles; Silva, Luis Lamberti Pinto da ; Lee, Robert J.; Lopez, Renata Fonseca Vianna
Source: Journal of Controlled Release. Unidades: SVOI, FMRP, FCFRP
Subjects: MODELOS ANIMAIS, CARCINOMA DE CÉLULAS ESCAMOSAS, TUMOR CARCINOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PETRILLI, Raquel et al. Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection. Journal of Controlled Release, v. 283, p. 151-162, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.jconrel.2018.05.038. Acesso em: 17 nov. 2024.
APA
Petrilli, R., Eloy, J. de O., Saggioro, F. P., Chesca, D. L., Souza, M. C. de, Dias, M. V. S., et al. (2018). Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection. Journal of Controlled Release, 283, 151-162. doi:10.1016/j.jconrel.2018.05.038
NLM
Petrilli R, Eloy J de O, Saggioro FP, Chesca DL, Souza MC de, Dias MVS, Silva LLP da, Lee RJ, Lopez RFV. Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection [Internet]. Journal of Controlled Release. 2018 ; 283 151-162.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.jconrel.2018.05.038
Vancouver
Petrilli R, Eloy J de O, Saggioro FP, Chesca DL, Souza MC de, Dias MVS, Silva LLP da, Lee RJ, Lopez RFV. Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection [Internet]. Journal of Controlled Release. 2018 ; 283 151-162.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.jconrel.2018.05.038
Artigo de periodico
Atypical cellular blue nevus or malignant blue nevus? (2017)
Daltro, Luise Ribeiro; Yaegashi, Lygia Bertalha; Freitas, Rodrigo Abdalah; Fantini, Bruno de Carvalho; Souza, Cacilda da Silva
Source: Anais Brasileiros de Dermatologia. Unidades: SVOI, FMRP
Subjects: CRIANÇAS, DIAGNÓSTICO DIFERENCIAL, NEOPLASIAS CUTÂNEAS, MELANOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DALTRO, Luise Ribeiro et al. Atypical cellular blue nevus or malignant blue nevus?. Anais Brasileiros de Dermatologia, v. 92, n. 1, p. 110-112, 2017Tradução . . Disponível em: https://doi.org/10.1590/abd1806-4841.20174502. Acesso em: 17 nov. 2024.
APA
Daltro, L. R., Yaegashi, L. B., Freitas, R. A., Fantini, B. de C., & Souza, C. da S. (2017). Atypical cellular blue nevus or malignant blue nevus? Anais Brasileiros de Dermatologia, 92( 1), 110-112. doi:10.1590/abd1806-4841.20174502
NLM
Daltro LR, Yaegashi LB, Freitas RA, Fantini B de C, Souza C da S. Atypical cellular blue nevus or malignant blue nevus? [Internet]. Anais Brasileiros de Dermatologia. 2017 ; 92( 1): 110-112.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1590/abd1806-4841.20174502
Vancouver
Daltro LR, Yaegashi LB, Freitas RA, Fantini B de C, Souza C da S. Atypical cellular blue nevus or malignant blue nevus? [Internet]. Anais Brasileiros de Dermatologia. 2017 ; 92( 1): 110-112.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1590/abd1806-4841.20174502
Artigo de periodico
Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy (2017)
Eloy, Josimar O.; Petrilli, Raquel; Chesca, Deise Lúcia; Saggioro, Fabiano Pinto; Lee, Robert J.; Marchetti, Juliana Maldonado
Source: European Journal of Pharmaceutics and Biopharmaceutics. Unidades: FMRP, SVOI, FCFRP
Subjects: ANTICORPOS MONOCLONAIS, NEOPLASIAS MAMÁRIAS, LIPOSSOMOS, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ELOY, Josimar O. et al. Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy. European Journal of Pharmaceutics and Biopharmaceutics, v. 115, p. 159-167, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2017.02.020. Acesso em: 17 nov. 2024.
APA
Eloy, J. O., Petrilli, R., Chesca, D. L., Saggioro, F. P., Lee, R. J., & Marchetti, J. M. (2017). Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy. European Journal of Pharmaceutics and Biopharmaceutics, 115, 159-167. doi:10.1016/j.ejpb.2017.02.020
NLM
Eloy JO, Petrilli R, Chesca DL, Saggioro FP, Lee RJ, Marchetti JM. Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2017 ; 115 159-167.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.ejpb.2017.02.020
Vancouver
Eloy JO, Petrilli R, Chesca DL, Saggioro FP, Lee RJ, Marchetti JM. Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2017 ; 115 159-167.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.ejpb.2017.02.020
Trabalho de evento-resumo
PTEN loss associates with STAT1/3 expression and intra-tumoral CD8+ density in prostate cancer (2016)
Vidotto, Thiago; Ouellet, Véronique; Saggioro, Fabiano Pinto; Caron, Christine; Fragoso, Gabriela; Mes-Masson, Anne-Marie; Saad, Fred; Siemens, D. Robert; Squire, Jeremy Andrew; Koti, Madhuri
Source: Abstracts. Conference titles: Cancer Genomics Group Meetings. Unidades: SVOI, FMRP
Subjects: NEOPLASIAS PROSTÁTICAS, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIDOTTO, Thiago et al. PTEN loss associates with STAT1/3 expression and intra-tumoral CD8+ density in prostate cancer. 2016, Anais.. Ontario: Queen's University, 2016. . Acesso em: 17 nov. 2024.
APA
Vidotto, T., Ouellet, V., Saggioro, F. P., Caron, C., Fragoso, G., Mes-Masson, A. -M., et al. (2016). PTEN loss associates with STAT1/3 expression and intra-tumoral CD8+ density in prostate cancer. In Abstracts. Ontario: Queen's University.
NLM
Vidotto T, Ouellet V, Saggioro FP, Caron C, Fragoso G, Mes-Masson A-M, Saad F, Siemens DR, Squire JA, Koti M. PTEN loss associates with STAT1/3 expression and intra-tumoral CD8+ density in prostate cancer. Abstracts. 2016 ;[citado 2024 nov. 17 ]
Vancouver
Vidotto T, Ouellet V, Saggioro FP, Caron C, Fragoso G, Mes-Masson A-M, Saad F, Siemens DR, Squire JA, Koti M. PTEN loss associates with STAT1/3 expression and intra-tumoral CD8+ density in prostate cancer. Abstracts. 2016 ;[citado 2024 nov. 17 ]
Artigo de periodico
Lymph node or perineural invasion is associated with low mirR-15a, miR-34c and miR-199b levels in head and neck squamous cell carcinoma (2016)
Sousa, Lucas O.; Sobral, Lays M.; Matsumoto, Camila S.; Saggioro, Fabiano Pinto; López, Rossana Verónica Mendoza; Panepucci, Rodrigo Alexandre; Curti, Carlos; Silva Júnior, Wilson Araújo da; Greene, Lewis Joel; Leopoldino, Andréia Machado
Source: BBA- Biochimica et Biophysica Acta. Clinical. Unidades: SVOI, FCFRP, FMRP
Subjects: LINFONODOS, CARCINOMA DE CÉLULAS ESCAMOSAS, DIAGNÓSTICO, TERAPÊUTICA MÉDICA, RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUSA, Lucas O. et al. Lymph node or perineural invasion is associated with low mirR-15a, miR-34c and miR-199b levels in head and neck squamous cell carcinoma. BBA- Biochimica et Biophysica Acta. Clinical, v. 6, p. 159-164, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.bbacli.2016.11.001. Acesso em: 17 nov. 2024.
APA
Sousa, L. O., Sobral, L. M., Matsumoto, C. S., Saggioro, F. P., López, R. V. M., Panepucci, R. A., et al. (2016). Lymph node or perineural invasion is associated with low mirR-15a, miR-34c and miR-199b levels in head and neck squamous cell carcinoma. BBA- Biochimica et Biophysica Acta. Clinical, 6, 159-164. doi:10.1016/j.bbacli.2016.11.001
NLM
Sousa LO, Sobral LM, Matsumoto CS, Saggioro FP, López RVM, Panepucci RA, Curti C, Silva Júnior WA da, Greene LJ, Leopoldino AM. Lymph node or perineural invasion is associated with low mirR-15a, miR-34c and miR-199b levels in head and neck squamous cell carcinoma [Internet]. BBA- Biochimica et Biophysica Acta. Clinical. 2016 ; 6 159-164.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.bbacli.2016.11.001
Vancouver
Sousa LO, Sobral LM, Matsumoto CS, Saggioro FP, López RVM, Panepucci RA, Curti C, Silva Júnior WA da, Greene LJ, Leopoldino AM. Lymph node or perineural invasion is associated with low mirR-15a, miR-34c and miR-199b levels in head and neck squamous cell carcinoma [Internet]. BBA- Biochimica et Biophysica Acta. Clinical. 2016 ; 6 159-164.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.bbacli.2016.11.001
Artigo de periodico
P27/CDKN1B translational regulators in pituitary tumorigenesis (2016)
Martins, C. S.; Camargo, R. C.; Saggioro, Fabiano Pinto; Neder, Luciano; Machado, Hélio Rubens; Moreira, Ayrton Custódio; Castro, Margaret de
Source: Hormone and Metabolic Research. Unidades: SVOI, FMRP
Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO, GLÂNDULA PITUITÁRIA, CONTROLE GÊNICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINS, C. S. et al. P27/CDKN1B translational regulators in pituitary tumorigenesis. Hormone and Metabolic Research, v. 48, n. 12, p. 840-846, 2016Tradução . . Disponível em: https://doi.org/10.1055/s-0042-118613. Acesso em: 17 nov. 2024.
APA
Martins, C. S., Camargo, R. C., Saggioro, F. P., Neder, L., Machado, H. R., Moreira, A. C., & Castro, M. de. (2016). P27/CDKN1B translational regulators in pituitary tumorigenesis. Hormone and Metabolic Research, 48( 12), 840-846. doi:10.1055/s-0042-118613
NLM
Martins CS, Camargo RC, Saggioro FP, Neder L, Machado HR, Moreira AC, Castro M de. P27/CDKN1B translational regulators in pituitary tumorigenesis [Internet]. Hormone and Metabolic Research. 2016 ; 48( 12): 840-846.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1055/s-0042-118613
Vancouver
Martins CS, Camargo RC, Saggioro FP, Neder L, Machado HR, Moreira AC, Castro M de. P27/CDKN1B translational regulators in pituitary tumorigenesis [Internet]. Hormone and Metabolic Research. 2016 ; 48( 12): 840-846.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1055/s-0042-118613
Artigo de periodico
Sarcoma radioinduzido pós-tratamento de glioblastoma: relato de caso (2016)
Rosa, Victor Domingos Lisita; Anjos, Caroline Souza dos; Candido, Priscila Barile Marchi; Dias Júnior, Antonio Soares; Santos, Evandro Airton Sordi dos; Godoy, Antonio Carlos Cavalcante; Saggioro, Fabiano Pinto; Carlotti Júnior, Carlos Gilberto; Oliveira, Harley Francisco de; Peria, Fernanda Maris
Source: Revista Brasileira de Cancerologia. Unidades: SVOI, FMRP
Subjects: SARCOMA, NEOPLASIAS DO SISTEMA NERVOSO, RADIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROSA, Victor Domingos Lisita et al. Sarcoma radioinduzido pós-tratamento de glioblastoma: relato de caso. Revista Brasileira de Cancerologia, v. 62, n. 1, p. 51-57, 2016Tradução . . Disponível em: file:///C:/Users/sandra/AppData/Local/Temp/09-relato-caso-sarcoma-radioinduzido-pos-tratamento-de-glioblastoma.pdf. Acesso em: 17 nov. 2024.
APA
Rosa, V. D. L., Anjos, C. S. dos, Candido, P. B. M., Dias Júnior, A. S., Santos, E. A. S. dos, Godoy, A. C. C., et al. (2016). Sarcoma radioinduzido pós-tratamento de glioblastoma: relato de caso. Revista Brasileira de Cancerologia, 62( 1), 51-57. Recuperado de file:///C:/Users/sandra/AppData/Local/Temp/09-relato-caso-sarcoma-radioinduzido-pos-tratamento-de-glioblastoma.pdf
NLM
Rosa VDL, Anjos CS dos, Candido PBM, Dias Júnior AS, Santos EAS dos, Godoy ACC, Saggioro FP, Carlotti Júnior CG, Oliveira HF de, Peria FM. Sarcoma radioinduzido pós-tratamento de glioblastoma: relato de caso [Internet]. Revista Brasileira de Cancerologia. 2016 ; 62( 1): 51-57.[citado 2024 nov. 17 ] Available from: file:///C:/Users/sandra/AppData/Local/Temp/09-relato-caso-sarcoma-radioinduzido-pos-tratamento-de-glioblastoma.pdf
Vancouver
Rosa VDL, Anjos CS dos, Candido PBM, Dias Júnior AS, Santos EAS dos, Godoy ACC, Saggioro FP, Carlotti Júnior CG, Oliveira HF de, Peria FM. Sarcoma radioinduzido pós-tratamento de glioblastoma: relato de caso [Internet]. Revista Brasileira de Cancerologia. 2016 ; 62( 1): 51-57.[citado 2024 nov. 17 ] Available from: file:///C:/Users/sandra/AppData/Local/Temp/09-relato-caso-sarcoma-radioinduzido-pos-tratamento-de-glioblastoma.pdf
Artigo de periodico
Sonic Hedgehog pathway is upregulated in adamantinomatous craniopharyngiomas (2015)
Gomes, D. C.; Jamra, S. A.; Leal, L. F.; Colli, L. M.; Campanini, M. L.; Oliveira, R. S.; Martinelli Junior, Carlos Eduardo; Elias, Paula Conde Lamparelli; Moreira, Ayrton Custódio; Machado, Hélio Rubens; Saggioro, Fabiano Pinto; Neder, Luciano; Castro, Margaret de; Antonini, Sonir Roberto Rauber
Source: European Journal of Endocrinology. Unidades: FMRP, SVOI
Subjects: EXPRESSÃO GÊNICA, NEOPLASIAS CRANIANAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, D. C. et al. Sonic Hedgehog pathway is upregulated in adamantinomatous craniopharyngiomas. European Journal of Endocrinology, v. 172, n. 5, p. 603-608, 2015Tradução . . Disponível em: https://doi.org/10.1530/EJE-14-0934. Acesso em: 17 nov. 2024.
APA
Gomes, D. C., Jamra, S. A., Leal, L. F., Colli, L. M., Campanini, M. L., Oliveira, R. S., et al. (2015). Sonic Hedgehog pathway is upregulated in adamantinomatous craniopharyngiomas. European Journal of Endocrinology, 172( 5), 603-608. doi:10.1530/EJE-14-0934
NLM
Gomes DC, Jamra SA, Leal LF, Colli LM, Campanini ML, Oliveira RS, Martinelli Junior CE, Elias PCL, Moreira AC, Machado HR, Saggioro FP, Neder L, Castro M de, Antonini SRR. Sonic Hedgehog pathway is upregulated in adamantinomatous craniopharyngiomas [Internet]. European Journal of Endocrinology. 2015 ; 172( 5): 603-608.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1530/EJE-14-0934
Vancouver
Gomes DC, Jamra SA, Leal LF, Colli LM, Campanini ML, Oliveira RS, Martinelli Junior CE, Elias PCL, Moreira AC, Machado HR, Saggioro FP, Neder L, Castro M de, Antonini SRR. Sonic Hedgehog pathway is upregulated in adamantinomatous craniopharyngiomas [Internet]. European Journal of Endocrinology. 2015 ; 172( 5): 603-608.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1530/EJE-14-0934
Artigo de periodico
Paraneoplastic dermatomyositis associated with neuroendocrine tumor of an unknown primary site: a case report (2015)
Anjos, Caroline Souza dos; Rosa, Victor Domingos Lisita; Godoy, Antonio Carlos Cavalcante; Thomé, João Luiz Chicchi; Rapatoni, Liane; Saggioro, Fabiano Pinto; Neder, Luciano; Oliveira, Rodrigo de; Oliveira, Harley Francisco de; Peria, Fernanda Maris
Source: Clinical Case Reports and Reviews (CCRR). Unidades: SVOI, FMRP
Subjects: DERMATOPATIAS, NEOPLASIAS, CARCINOMA NEUROENDÓCRINO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANJOS, Caroline Souza dos et al. Paraneoplastic dermatomyositis associated with neuroendocrine tumor of an unknown primary site: a case report. Clinical Case Reports and Reviews (CCRR), v. 1, n. 6, p. 114-117, 2015Tradução . . Disponível em: https://doi.org/10.15761/CCRR.1000138. Acesso em: 17 nov. 2024.
APA
Anjos, C. S. dos, Rosa, V. D. L., Godoy, A. C. C., Thomé, J. L. C., Rapatoni, L., Saggioro, F. P., et al. (2015). Paraneoplastic dermatomyositis associated with neuroendocrine tumor of an unknown primary site: a case report. Clinical Case Reports and Reviews (CCRR), 1( 6), 114-117. doi:10.15761/CCRR.1000138
NLM
Anjos CS dos, Rosa VDL, Godoy ACC, Thomé JLC, Rapatoni L, Saggioro FP, Neder L, Oliveira R de, Oliveira HF de, Peria FM. Paraneoplastic dermatomyositis associated with neuroendocrine tumor of an unknown primary site: a case report [Internet]. Clinical Case Reports and Reviews (CCRR). 2015 ; 1( 6): 114-117.[citado 2024 nov. 17 ] Available from: https://doi.org/10.15761/CCRR.1000138
Vancouver
Anjos CS dos, Rosa VDL, Godoy ACC, Thomé JLC, Rapatoni L, Saggioro FP, Neder L, Oliveira R de, Oliveira HF de, Peria FM. Paraneoplastic dermatomyositis associated with neuroendocrine tumor of an unknown primary site: a case report [Internet]. Clinical Case Reports and Reviews (CCRR). 2015 ; 1( 6): 114-117.[citado 2024 nov. 17 ] Available from: https://doi.org/10.15761/CCRR.1000138
Trabalho de evento-resumo
Potential role of BTG2 gene in the molecular pathogenesis of the non-functioning pituitary adenomas (2015)
Camargo, Renata Costa; Martins, Clarissa Silva; Saggioro, Fabiano Pinto; Neder, Luciano; Machado, Hélio Rubens; Moreira, Ayrton Custódio; Castro, Margaret de
Source: Abstracts. Conference titles: Annual Meeting and Expo of the Endocrine Society (ENDO). Unidades: FMRP, SVOI
Subjects: EXPRESSÃO GÊNICA, HORMÔNIO DO CRESCIMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMARGO, Renata Costa et al. Potential role of BTG2 gene in the molecular pathogenesis of the non-functioning pituitary adenomas. 2015, Anais.. San Diego: Endocrine Society, 2015. Disponível em: http://press.endocrine.org/doi/abs/10.1210/endo-meetings.2015.TB.8.FRI-350. Acesso em: 17 nov. 2024.
APA
Camargo, R. C., Martins, C. S., Saggioro, F. P., Neder, L., Machado, H. R., Moreira, A. C., & Castro, M. de. (2015). Potential role of BTG2 gene in the molecular pathogenesis of the non-functioning pituitary adenomas. In Abstracts. San Diego: Endocrine Society. Recuperado de http://press.endocrine.org/doi/abs/10.1210/endo-meetings.2015.TB.8.FRI-350
NLM
Camargo RC, Martins CS, Saggioro FP, Neder L, Machado HR, Moreira AC, Castro M de. Potential role of BTG2 gene in the molecular pathogenesis of the non-functioning pituitary adenomas [Internet]. Abstracts. 2015 ;[citado 2024 nov. 17 ] Available from: http://press.endocrine.org/doi/abs/10.1210/endo-meetings.2015.TB.8.FRI-350
Vancouver
Camargo RC, Martins CS, Saggioro FP, Neder L, Machado HR, Moreira AC, Castro M de. Potential role of BTG2 gene in the molecular pathogenesis of the non-functioning pituitary adenomas [Internet]. Abstracts. 2015 ;[citado 2024 nov. 17 ] Available from: http://press.endocrine.org/doi/abs/10.1210/endo-meetings.2015.TB.8.FRI-350
Artigo de periodico
Telomere length and telomerase expression in pituitary tumors (2015)
Martins, C. S; Santana-Lemos, Bárbara Amélia Aparecida; Saggioro, Fabiano Pinto; Neder, Luciano; Machado, Hélio Rubens; Moreira, Ayrton Custódio; Calado, Rodrigo Tocantins; Castro, Margaret de
Source: Journal of Endocrinological Investigation. Unidades: FMRP, SVOI
Subjects: NEOPLASIAS HIPOFISÁRIAS, DNA POLIMERASES, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINS, C. S et al. Telomere length and telomerase expression in pituitary tumors. Journal of Endocrinological Investigation, v. 38, n. 11, p. 1243-1246, 2015Tradução . . Disponível em: https://doi.org/10.1007/s40618-015-0298-3. Acesso em: 17 nov. 2024.
APA
Martins, C. S., Santana-Lemos, B. A. A., Saggioro, F. P., Neder, L., Machado, H. R., Moreira, A. C., et al. (2015). Telomere length and telomerase expression in pituitary tumors. Journal of Endocrinological Investigation, 38( 11), 1243-1246. doi:10.1007/s40618-015-0298-3
NLM
Martins CS, Santana-Lemos BAA, Saggioro FP, Neder L, Machado HR, Moreira AC, Calado RT, Castro M de. Telomere length and telomerase expression in pituitary tumors [Internet]. Journal of Endocrinological Investigation. 2015 ; 38( 11): 1243-1246.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1007/s40618-015-0298-3
Vancouver
Martins CS, Santana-Lemos BAA, Saggioro FP, Neder L, Machado HR, Moreira AC, Calado RT, Castro M de. Telomere length and telomerase expression in pituitary tumors [Internet]. Journal of Endocrinological Investigation. 2015 ; 38( 11): 1243-1246.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1007/s40618-015-0298-3
Artigo de periodico
Halofuginone inhibits phosphorylation of SMAD-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model (2015)
Assis, Patricia A; Figueiredo-Pontes, Lorena L. de; Lima, Ana Silvia G; Leão, Vitor; Cândido, Larissa A; Pintão, Carolina T; Garcia, Aglair B; Saggioro, Fabiano Pinto; Panepucci, Rodrigo A; Chahud, Fernando; Nagler, Arnon; Falcão, Roberto Passetto; Rego, Eduardo Magalhaes
Source: Journal of Experimental and Clinical Cancer Research. Unidades: SVOI, FMRP
Subjects: ALCALOIDES, ENDOTÉLIO VASCULAR, LEUCEMIA MIELOIDE, MODELOS ANIMAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ASSIS, Patricia A et al. Halofuginone inhibits phosphorylation of SMAD-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model. Journal of Experimental and Clinical Cancer Research, v. 34, n. ju, 2015Tradução . . Disponível em: https://doi.org/10.1186/s13046-015-0181-2. Acesso em: 17 nov. 2024.
APA
Assis, P. A., Figueiredo-Pontes, L. L. de, Lima, A. S. G., Leão, V., Cândido, L. A., Pintão, C. T., et al. (2015). Halofuginone inhibits phosphorylation of SMAD-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model. Journal of Experimental and Clinical Cancer Research, 34( ju). doi:10.1186/s13046-015-0181-2
NLM
Assis PA, Figueiredo-Pontes LL de, Lima ASG, Leão V, Cândido LA, Pintão CT, Garcia AB, Saggioro FP, Panepucci RA, Chahud F, Nagler A, Falcão RP, Rego EM. Halofuginone inhibits phosphorylation of SMAD-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model [Internet]. Journal of Experimental and Clinical Cancer Research. 2015 ; 34( ju):[citado 2024 nov. 17 ] Available from: https://doi.org/10.1186/s13046-015-0181-2
Vancouver
Assis PA, Figueiredo-Pontes LL de, Lima ASG, Leão V, Cândido LA, Pintão CT, Garcia AB, Saggioro FP, Panepucci RA, Chahud F, Nagler A, Falcão RP, Rego EM. Halofuginone inhibits phosphorylation of SMAD-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model [Internet]. Journal of Experimental and Clinical Cancer Research. 2015 ; 34( ju):[citado 2024 nov. 17 ] Available from: https://doi.org/10.1186/s13046-015-0181-2
Artigo de periodico
Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection (2014)
López, Rossana Verónica Mendoza; Levi, José Eduardo; Eluf-Neto, José; Koifman, Rosalina Jorge; Koifman, Sergio; Curado, Maria Paula; Michaluart-Junior, Pedro; Figueiredo, David Livingstone Alves; Saggioro, Fabiano Pinto; Carvalho, Marcos Brasilino de; Kowalski, Luiz Paulo; Abrahão, Márcio; Góis-Filho, Francisco de; Tajara, Eloiza Helena; Waterboer, Tim; Boffetta, Paolo; Brennan, Paul; Wünsch-Filho, Victor
Source: Cancer causes control. Unidades: FM, FSP, SVOI
Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO, INFECÇÕES POR VÍRUS DE DNA, FATORES DE RISCO, CARCINOMA DE CÉLULAS ESCAMOSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LÓPEZ, Rossana Verónica Mendoza et al. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection. Cancer causes control, v. 25, n. 4, p. 461-471, 2014Tradução . . Disponível em: https://doi.org/10.1007/s10552-014-0348-8. Acesso em: 17 nov. 2024.
APA
López, R. V. M., Levi, J. E., Eluf-Neto, J., Koifman, R. J., Koifman, S., Curado, M. P., et al. (2014). Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection. Cancer causes control, 25( 4), 461-471. doi:10.1007/s10552-014-0348-8
NLM
López RVM, Levi JE, Eluf-Neto J, Koifman RJ, Koifman S, Curado MP, Michaluart-Junior P, Figueiredo DLA, Saggioro FP, Carvalho MB de, Kowalski LP, Abrahão M, Góis-Filho F de, Tajara EH, Waterboer T, Boffetta P, Brennan P, Wünsch-Filho V. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection [Internet]. Cancer causes control. 2014 ; 25( 4): 461-471.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1007/s10552-014-0348-8
Vancouver
López RVM, Levi JE, Eluf-Neto J, Koifman RJ, Koifman S, Curado MP, Michaluart-Junior P, Figueiredo DLA, Saggioro FP, Carvalho MB de, Kowalski LP, Abrahão M, Góis-Filho F de, Tajara EH, Waterboer T, Boffetta P, Brennan P, Wünsch-Filho V. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection [Internet]. Cancer causes control. 2014 ; 25( 4): 461-471.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1007/s10552-014-0348-8

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation